A novel route to radioiodinated [123I]-N-succinimidyl-3-iodobenzoate, a reagent for radioiodination of bioactive peptides

Applied Radiation and Isotopes

Volumn 57, Issue 5, 2002, Pages 743-747

  Al Jammaz, I ^a   Al Otaibi, B ^a   Amartey, J K ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Iodine 123; Meta iodobenzylguanidine; Peptides; Prosthetic radioiodination

Indexed keywords

ESTERS; IODINE; PROSTHETICS; PROTEINS; RADIOTHERAPY; TUMORS;

RADIOIODINATION;

RADIOISOTOPES;

(3 IODOBENZYL)GUANIDINE I 123; CHEMOTACTIC PEPTIDE; ESTER DERIVATIVE; LYSINE; N SUCCINIMIDYL 3 IODOBENZOATE I 123; RADIOPHARMACEUTICAL AGENT; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; CANCER; DRUG ACTIVITY; DRUG LABELING; EVALUATION; GRAFT REJECTION; IN VIVO STUDY; INFLAMMATION; ISOTOPE LABELING; PRECURSOR; PRIORITY JOURNAL; RADIOIODINATION; SOLID STATE;

ANIMALS; DRUG STABILITY; IODINE RADIOISOTOPES; IODOBENZOATES; MICE; PEPTIDES; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION;

EID: 0036842049     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8043(02)00191-4     Document Type: Article

References (15)

1. 124I]-mIBG. Appl. Radiat. Isot. 54:2001;711-714.
2. Amartey J.K., Parhar R.S., Al-Jammaz I. Synthesis and preliminary evaluation of Tc-99m-labeled somatostatin analog (RC-160) using "3+1" mixed ligand approach. Nucl. Med. Biol. 28:2001;225-233.
3. 125I-containing acylating agent. Biochem. J. 133:1973;529-539.
4. 3] octreotide Eur. J. Nucl. Med. 20:1993;1089-1095.
5. Dewanjee, M.K., 1992. Radioiodination: Theory, Practice and Biomedical Applications. Kluwer Academic Press, London, pp. 69-117 (Chapter 7).
6. 125I labeled N-succinimidyl p-iodobenzoate for use in radiolabeling antibodies. Nucl. Med. Biol. 16:1989;727.
7. Lambrecht R.M., Sajjad M., Syed R.M.et al. Target preparation and recovery of enriched isotopes for medical radionuclide production. Nucl. Instrum. Meth. Phys. Res. A. 282:1989;296.
8. Sudha G., Pradeep K.G., Zalutsky M.R.et al. Radioiodination of a monoclonal antibody using N-succinimidyl 5-Iodo-3-pyridinecarboxylate. Nucl. Med. Biol. 20:1993;835-842.
9. 123I]-iodobenzylguanidine. synthesis and preliminary evaluation Nucl. Med. Biol. 22:1995;61-64.
10. Vaidyanathan G., Zalutsky M.R. Fluorine-18 labeled chemotactic peptides. a potential approach for the pet imaging of bacterial infection Nucl. Med. Biol. 22:1995;759-764.
11. 131I-iodobenzylguanidine J. Nucl. Med. 21:1980;349-353.
12. Wilbur D.S., Hadley S.W., Hylarides M.D., Abrams P.G., Beaumier P.A., Morgan A.C., Fritzberg A.R. Development of a stable radioiodinating reagent to label monoclonal antibodies for radiotherapy of cancer. J. Nucl. Med. 30:1989;216-226.
13. Wilbur D.S., Hadley S.W., Grant L.M., Hylarides M.D. Radioiodinated iodobenzoyl conjugates of a monoclonal antibody fab fragment. In vivo comparisons with chloramine-T-labeled fab. Bioconjugate Chem. 2:1991;111.
14. Zalutsky M.R., Narula A.S. A method for the radiohalogenation of proteins resulting in decreased thyroid uptake of radioiodine. Appl. Radiat. Isot. 38:1987;1051-1055.
15. Zalutsky M.R., Noska M.A., Colapinto E.V., Garg P.K., Bigner D.D. Enhanced tumor localization and in vivo stability of a monoclonal antibody radioiodinated using N-succinimidyl 3-(tri-n-butylstannyl) benzoate. Cancer Res. 49:1989;5543.